Register for our free email digests:
Merck & Co. Inc.
www.merck.com
Latest From Merck & Co. Inc.
Deal Watch: Themis Leverages Measles Vector Platform In Collaboration With Merck & Co.
In its first big pharma deal, Austrian biotech will develop experimental vaccines for Merck against an undisclosed target. Innovent licenses Chinese rights to Lilly diabetes candidate, while Novartis gets option to Iconic’s preclinical ophthalmology program.
ICER Value Framework Update Reaffirms Support For Real-World Evidence
Drug makers have sought a larger role for RWE in ICER's review process; proposed update also includes process to re-evaluate cost-effectiveness evidence after one year.
Longer Intervals OK With ViiV's Injectable Anti-HIV Regimen
Topline results from the Phase III ATLAS-2M study indicate that injections every two months of ViiV/Janssen’s two-drug anti-HIV regimen are non-inferior to a once-monthly injectable regimen.
Can’t Let Go: HHS Seeks To Overturn US Court Decision Striking Down DTC Ad Rule
The appeal is in keeping with the President Trump’s plan to stay active on drug pricing initiatives so he can claim victory on a key campaign promise.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
- Therapeutic Areas
- Cardiovascular
- Gynecological, Urological
- Infectious & Viral Diseases
- Inflammation
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Ophthalmic
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Merck & Co. Inc.
- Abello SA
- Abmaxis Inc.
- Afferent Pharmaceuticals Inc.
- American Biodyne
- Assured Health Systems
- Bone Measurement Institute
- BritCair Ltd.
- cCAM Biotherapeutics Ltd.
- Cubist Pharmaceuticals Inc.
- GlycoFi Inc.
- Hangzhou MSD Pharmaceutical Co. Ltd.
- Idenix Pharmaceuticals Inc.
- Inspire Pharmaceuticals Inc.
- IOmet Pharma Ltd.
- Merck BioVentures
- Merck Consumer Healthcare Group
- Merck Frosst Canada Inc.
- Merck Genome Research Institute
- Merck Human Health Division
- Merck Research Laboratories
- Merck Sharp & Dohme Ltd.
- Merck Specialty Chemicals Group
- Merck Vaccine Division
- Merck-Supera Farma JV
- MSD Consumer Care Inc.
- MSD India
- MSD KK
- NovaCardia Inc.
- Oncoethix SA
- Rigontec GMBH
- Rosetta Inpharmatics LLC
-
Schering-Plough Corp.
- Canji Inc.
- DNAX Research Institute
- Essex Chemie AG
- Integrated Therapeutics Group Inc.
- Key Pharmaceuticals Inc.
- NeoGenesis Pharmaceuticals Inc.
- Organon NV
- Schering Canada
- Schering Corp.
- Schering Laboratories
- Schering-Plough (Brinny) Co.
- Schering-Plough Healthcare Products Inc.
- Schering-Plough Ltd.
- Schering-Plough Pharmaceuticals
- Schering-Plough Research Institute
- Scholl International
- Scholl US Division
- Shanghai Schering-Plough Pharmaceutical Co. Ltd.
- Warrick Pharmaceuticals
- Sibia Neurosciences Inc.
- SmartCells Inc.
- SMSD (Shanghai) Ltd.
- SysteMed Inc.
- Viralytics Ltd.
- West Point Pharma
- Senior Management
-
Kenneth C Frazier, CEO
Robert M Davis, EVP, CFO - Contact Info
-
Merck & Co. Inc.
Phone: (908) 740-4000
2000 Galloping Hill Rd.
Kenilworth, NJ 07033
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice